title: Early neurosyphilis with etanercept treatment.
authors.affiliation: Service de Dermatologie, CHRU Dupuytren, 2 avenue Martin Luther King, 87042 Limoges cedex, France.
authors.forename: Safae
authors.initials: S
authors.lastname: Assikar
authors.affiliation: Service de Dermatologie, CHRU Dupuytren, 2 avenue Martin Luther King, 87042 Limoges cedex, France.
authors.forename: Valérie
authors.initials: V
authors.lastname: Doffoel-Hantz
authors.affiliation: Service de Dermatologie, CHRU Dupuytren, 2 avenue Martin Luther King, 87042 Limoges cedex, France.
authors.forename: Agnès
authors.initials: A
authors.lastname: Sparsa
authors.affiliation: Service de Dermatologie, CHRU Dupuytren, 2 avenue Martin Luther King, 87042 Limoges cedex, France.
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Bonnetblanc
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009494:Neurosyphilis / Q000139:chemically induced* / Q000175:diagnosis; D018124:Receptors, Tumor Necrosis Factor; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept